For the molecular mechanisms in breast cancer, metformin activates AMP-activated protein kinase (AMPK) and leads to the inhibition of mTOR signaling and protein synthesis, which is responsible for the cancer cell proliferation32. This evidence concerns the gene MTOR and breast carcinoma.